Abstract 3156: A surface plasmon resonance-based screening platform to identify potential PD-1/PD-L1 inhibitors from a FDA-approved drugs library for cancer immunotherapy
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Huifang Li, Ang Cai, Navindra P. Seeram, Chang Liu
Institution: University of Rhode Island
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409631411